de Lafuente Y, Quarta E, Magi M, Apas A, Pagani J, Palena M
Antibiotics (Basel). 2025; 14(2).
PMID: 40001413
PMC: 11851662.
DOI: 10.3390/antibiotics14020169.
Baroni D
Curr Issues Mol Biol. 2025; 47(2).
PMID: 39996840
PMC: 11854517.
DOI: 10.3390/cimb47020119.
Schator D, Kumar N, Chong S, Jung T, Jedel E, Smith B
bioRxiv. 2025; .
PMID: 39975129
PMC: 11839010.
DOI: 10.1101/2025.02.09.637186.
Sithu Shein A, Hongsing P, Khatib A, Phattharapornjaroen P, Miyanaga K, Cui L
NPJ Antimicrob Resist. 2025; 2(1):31.
PMID: 39843534
PMC: 11721074.
DOI: 10.1038/s44259-024-00045-4.
Coelho L, de Souza Terceti M, Neto S, Amaral R, Dos Santos A, Gozzi W
Commun Biol. 2025; 8(1):13.
PMID: 39762450
PMC: 11704353.
DOI: 10.1038/s42003-024-07269-0.
Phage therapy to treat cystic fibrosis complex lung infections: perspectives and challenges.
Canning J, Laucirica D, Ling K, Nicol M, Stick S, Kicic A
Front Microbiol. 2024; 15:1476041.
PMID: 39493847
PMC: 11527634.
DOI: 10.3389/fmicb.2024.1476041.
A New Frontier in Cystic Fibrosis Pathophysiology: How and When Clock Genes Can Affect the Inflammatory/Immune Response in a Genetic Disease Model.
Carbone A, Vitullo P, Di Gioia S, Castellani S, Conese M
Curr Issues Mol Biol. 2024; 46(9):10396-10410.
PMID: 39329970
PMC: 11430433.
DOI: 10.3390/cimb46090618.
The airway mycobiome and interactions with immunity in health and chronic lung disease.
Katsoulis O, Pitts O, Singanayagam A
Oxf Open Immunol. 2024; 5(1):iqae009.
PMID: 39206335
PMC: 11357796.
DOI: 10.1093/oxfimm/iqae009.
Genome-wide association study of susceptibility to infection in cystic fibrosis.
Lin B, Gong J, Keenan K, Lin F, Lin Y, Mesinele J
Eur Respir J. 2024; 64(5).
PMID: 39117430
PMC: 11540985.
DOI: 10.1183/13993003.00062-2024.
Impact of Growth Conditions on High-Throughput Identification of Repurposing Drugs for Cystic Fibrosis Lung Infections.
Di Bonaventura G, Lupetti V, Pompilio A
Antibiotics (Basel). 2024; 13(7).
PMID: 39061324
PMC: 11273527.
DOI: 10.3390/antibiotics13070642.
Zinc status in cystic fibrosis patients; a systematic review and meta-analysis.
Malekahmadi M, Soltani S, Pahlavani N, Sharifi Zahabi E, Kazemizadeh H, Hadavi S
Heliyon. 2024; 10(13):e33686.
PMID: 39027558
PMC: 11255513.
DOI: 10.1016/j.heliyon.2024.e33686.
in chronic lung disease: untangling the dysregulated host immune response.
Nickerson R, Thornton C, Johnston B, Lee A, Cheng Z
Front Immunol. 2024; 15:1405376.
PMID: 39015565
PMC: 11250099.
DOI: 10.3389/fimmu.2024.1405376.
Antibacterial potential of complex cystic fibrosis isolates.
Crisan C, Pettis M, Goldberg J
mSphere. 2024; 9(7):e0033524.
PMID: 38980073
PMC: 11288042.
DOI: 10.1128/msphere.00335-24.
Bactericidal effectors of the type IV secretion system: functional definition of the nuclease TfdA and structural determination of TfcB.
Cobe B, Dey S, Minasov G, Inniss N, Satchell K, Cianciotto N
mBio. 2024; 15(7):e0119824.
PMID: 38832773
PMC: 11253643.
DOI: 10.1128/mbio.01198-24.
Considerations for the use of inhaled antibiotics for in people with cystic fibrosis receiving CFTR modulator therapy.
Burgel P, Ballmann M, Drevinek P, Heijerman H, Jung A, Mainz J
BMJ Open Respir Res. 2024; 11(1).
PMID: 38702073
PMC: 11086488.
DOI: 10.1136/bmjresp-2023-002049.
Novel Dry Hyaluronic Acid-Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis.
Magi M, de Lafuente Y, Quarta E, Palena M, Ardiles P, Paez P
Pharmaceutics. 2024; 16(4).
PMID: 38675098
PMC: 11054002.
DOI: 10.3390/pharmaceutics16040436.
Diversity of CFTR variants across ancestries characterized using 454,727 UK biobank whole exome sequences.
Ideozu J, Liu M, Riley-Gillis B, Paladugu S, Rahimov F, Krishnan P
Genome Med. 2024; 16(1):43.
PMID: 38515211
PMC: 10956269.
DOI: 10.1186/s13073-024-01316-5.
transcriptome analysis of metal restriction in cystic fibrosis sputum.
Neff S, Doing G, Reiter T, Hampton T, Greene C, Hogan D
Microbiol Spectr. 2024; 12(4):e0315723.
PMID: 38385740
PMC: 10986534.
DOI: 10.1128/spectrum.03157-23.
Lung microbiome: new insights into the pathogenesis of respiratory diseases.
Li R, Li J, Zhou X
Signal Transduct Target Ther. 2024; 9(1):19.
PMID: 38228603
PMC: 10791971.
DOI: 10.1038/s41392-023-01722-y.
Structure-preserving fixation allows scanning electron microscopy to reveal biofilm microstructure and interactions with immune cells.
Wells M, Mikesh M, Gordon V
J Microsc. 2023; 293(1):59-68.
PMID: 38098170
PMC: 10764082.
DOI: 10.1111/jmi.13252.